MedPath

Effects of hypocaloric diets at different glucose load on endothelial function and glycaemic variability in adult obese subjects with increased cardiovascular risk

Completed
Conditions
Cardiovascular and metabolic diseases
clinical nutrition
Nutritional, Metabolic, Endocrine
Registration Number
ISRCTN56834511
Lead Sponsor
niversity of Palermo (Italy)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
80
Inclusion Criteria

1. Male and female subjects
2. Range of age 18 - 60 years
3. Range of body mass index (BMI) 28 - 39.9 kg/m^2
4. Presence of at least one of the diagnostic criteria of the metabolic syndrome:
4.1. Waist circumference greater than 80 cm for women and 94 cm for men
4.2. Triglycerides greater than 150 mg/dl or use of lowering blood lipid drugs
4.3. High density lipoproteins (HDL)-cholesterol less than 50 mg/dl for women or 40 mg/dl for men
4.4. Blood pressure greater than 130 mmHg for systolic or greater than 85 mmHg for diastolic blood pressure
4.5. Fasting plasma glucose greater than 100 mg/dl

Exclusion Criteria

1. Type 1 or 2 diabetes
2. Gastro-intestinal, connective diseases
3. Chronic pancreatitis, liver cirrhosis, kidney stones, renal failure
4. Use of acetyl-salicylic acid (ASA), other antiplatelet drugs, statins, oral hypoglycemic drugs, nitrates, non-steroidal anti-inflammatory drugs (NSAIDS), corticosteroids, drugs interfering with coagulation, supplements with vitamins and anti-oxidants
5. Pregnancy or lactation in the last six months
6. Regular sport activity
7. Denial of informed consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Endothelial function, measured as flow mediated dilation<br>2. Glycaemic variability, measured by the subcutaneous continuous glucose monitoring method<br><br>These measurements will be obtained three times, respectively before (0 months), after hypocaloric diet (3 months) and body weight maintenance periods (12 months).
Secondary Outcome Measures
NameTimeMethod
1. Traditional anthropometric, metabolic and cardiovascular risk factors <br>2. Intra-renal haemodynamic measurements (resistance and pulsatility indexes)<br>3. Carotid intima-media thickness <br><br>These measurements will be obtained three times, respectively before (0 months), after hypocaloric diet (3 months) and body weight maintenance periods (12 months).
© Copyright 2025. All Rights Reserved by MedPath